Helicos Slashes Instrument Price by 25 Percent, Obtains Order from the University of Maryland | GenomeWeb

This article has been updated from a prior version to include additional information.

Helicos BioSciences has reduced the price of its single-molecule Helicos Genetic Analysis sequencing system by about 25 percent to $999,000, company officials said at the JPMorgan Healthcare Conference in San Francisco last week.

Helicos has also received an order for the instrument from the University of Maryland, the company's third customer since it launched its instrument at the beginning of last year, according to the officials.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.